Table 1.

Comparison between six other cases of MI associated with steroid use.

Case	Ferenchick and Adelman [14]	Yildirim et al. [15]	Arslan et al. [16]	Takamatsu et al. [17]	Owecki and Sowiński [18]	Poorzand et al. [2]
Age (years)	37	64	20	79	66	23
Risk factors	Family history of CAD	HLD	Smoking (7 years)	Bortezomib use	Smoking HLD
Gender	Male	Male	Male	Female	Female	Male
Steroid type	Nandrolone-decanoate, Boldenone, testosterone-cypionate, Stanozolol, and veterinary oxandrolone	Prednisolone	Methylprednisolone	Dexamethasone	Methylprednisolone	Dexamethasone
Indication	Anabolic steroids (weightlifting)	Idiopathic intracranial HTN (papilledema)	Anaphylaxis	Multiple myeloma	Graves	Anabolic steroids (wrestling)
Route	Intramuscular & oral	Oral	Intravenous	Intravenous	Intravenous	Intramuscular
Dose	200 mg/week for 16 weeks 1.5 cc q3 days/16 weeks 1.5 cc q4 days/16 weeks 1.5 cc q3 days/16 weeks 50 mg daily for 16 weeks	40 mg daily	40 mg	NA	1 gm daily	NA
Duration of use	Intermittent for 7 years and then 16 weeks before the event	One month	7 minutes	5 days	5 days	6 months
Possible confounders			Hypotension secondary to anaphylaxis	Bortezomib use
Acute coronary syndrome type	STEMI	NSTEMI and then STEMI few days later	STEMI	STEMI	NSTEMI	STEMI
EKG	ST elevation, II, III, and aVF	ST elevation, II, III, and aVF; ST depression, I, aVL	ST elevation, I, aVL	ST elevation, aVR; ST depression, I, II, and aVF V2–6	NA	ST elevation, I, aVL
Echo	Normal	Normal	EF 35% apical & posterolateral wall motion abnormality	EF 68% posterior & anterolateral akinesia	Anteroseptal akinesia	EF 35% apical, midanterior, anteroseptal akinesia
Left heart catheterization findings	Normal coronaries (3 days following tissue plasminogen activator)	RCA: slow flow and then PDA total occlusion & LAD slow flow	Normal coronaries 10 days later (normal IVUS) (treated with Aspirin & Heparin)	LM/LCX significant lesions LAD mod stenosis	LAD total occlusion RCA critical stenosis	Nonobstructive CAD (4 days after streptokinase)
Complications						LV thrombus